newsfilter
← Latest News
GlobeNewswire·

Anteris Reports Medium-Size DurAVR THV Outcomes from the EMBARK Study at TCT 2026

MINNEAPOLIS and BRISBANE, Australia, Nov. 01, 2026 (GLOBE NEWSWIRE) -- Anteris Technologies Global Corp. ("Anteris" or the "Company") (NASDAQ:AVR, ASX: AVR)) a global healthcare company committed to